Genmab A/S (GNMSF) Other Non-Current Liabilities (2019 - 2026)
Genmab A's (GNMSF) quarterly Other Non-Current Liabilities came in at $4.0 in Q3 2020, down 100.0% YoY from $1.9 million in Q4 2019, and up 100.0% on a QoQ basis from $2.0 in Q4 2019.
Genmab A/S (GNMSF) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Genmab A (GNMSF) has 2 years of Other Non-Current Liabilities data on file, last reported at $4.0 in Q3 2020.
- Quarterly Other Non-Current Liabilities fell 100.0% year-over-year to $4.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $4.0 (down 100.0% YoY) and the FY2019 annual result came in at $2.0, changed N/A from the prior year.
- Other Non-Current Liabilities climbed to $4.0 in Q3 2020, from $2.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q3 2019 to a low of $2.0 in Q4 2019.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861.00 Mn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 602.00 Mn |
| Jun 30, 2025 | 567.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 489.00 Mn |
| Sep 30, 2020 | 4.00 |
| Dec 31, 2019 | 2.00 |
| Sep 30, 2019 | 1.86 Mn |